141-30-0, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 141-30-0, name is 3,6-Dichloropyridazine, introducing its new discovery.
ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
Disclosed herein are substituted hexahydro-lH-cyclopenta[c]pyrrole compounds, which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.141-30-0, you can also check out more blogs about141-30-0
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1433 – PubChem